CirrhosisEDUCATE-CNCT07216807
EDUCATE-C: Education on Cirrhosis -- Assessing Text vs Video
A study testing Video Education and Text education in people with Cirrhosis, run by University of Michigan at 1 site in United States.
Trial summary
A randomized controlled trial of written text vs video education to patients with cirrhosis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cirrhosis
- What is being tested?
- Video Education and Text education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 218 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jun 2023to 20 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Cirrhosis diagnosis
Who cannot join
- Age under 18 years
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Randomized Trial of Text vs. Video Patient Educational Materials in Cirrhosis
A randomized controlled trial of written text vs video education to patients with cirrhosis.
- Conditions
- Cirrhosis
- Being tested
- Video Education, Text education
- Medical subject headings
- Fibrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Video EducationOther
Video education was provided from the cirrhosis.ca website.
Text educationOther
Text education was provided from the University of Michigan patient education materials
| Study group | Role | What they receive |
|---|---|---|
| General cirrhosis text | Other | These patients received TEXT education, and the subject was general cirrhosis knowledge. Receives: Other: Text education |
| General cirrhosis video | Other | These patients received VIDEO education, and the subject was general cirrhosis knowledge. Receives: Other: Video Education |
| Decompensation text | Other | These patients received TEXT education, and the subject was decompensated cirrhosis knowledge. Receives: Other: Text education |
| Decompensation video | Other | These patients received VIDEO education, and the subject was general cirrhosis knowledge. Receives: Other: Video Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Delta knowledge scores between text and video education groups
The delta score (post test minus pre test) was compared between text education and video education groups.
Measured: Baseline and immediately post-intervention (Day 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2025
- Study start1 Jun 2023
- Primary completion20 Jun 2025
- Study completion20 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CirrhosisStudies of the same condition, open and under way.
- More trials run by University of MichiganThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 218 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Michigan
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Patricia Bloom, University of Michigan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07216807
- Sponsor's protocol ID
- HUM00204958
- Acronym
- EDUCATE-C
- Status last verified
- Oct 2025
- First submitted
- 29 Sep 2025
- Last updated
- 15 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Trial of Text vs. Video Patient Educational Materials in Cirrhosis
- ClinicalTrials.gov ID
- NCT07216807
- Acronym / sponsor ID
- EDUCATE-C / HUM00204958
- Conditions
- Cirrhosis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 218 participants (actual)
- Lead sponsor
- University of MichiganUniversity, hospital or other
- Study start
- 1 Jun 2023 (actual)
- Primary completion
- 20 Jun 2025 (actual)
- Study completion
- 20 Jun 2025 (actual)
- First posted
- 15 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A randomized controlled trial of written text vs video education to patients with cirrhosis.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| General cirrhosis text | Other | Other: Text educationThese patients received TEXT education, and the subject was general cirrhosis knowledge. |
| General cirrhosis video | Other | Other: Video EducationThese patients received VIDEO education, and the subject was general cirrhosis knowledge. |
| Decompensation text | Other | Other: Text educationThese patients received TEXT education, and the subject was decompensated cirrhosis knowledge. |
| Decompensation video | Other | Other: Video EducationThese patients received VIDEO education, and the subject was general cirrhosis knowledge. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Cirrhosis diagnosis
Key exclusion criteria (1 listed)
- Age under 18 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Video EducationVideo education was provided from the cirrhosis.ca website. | Other | Decompensation video, General cirrhosis video |
| Text educationText education was provided from the University of Michigan patient education materials | Other | Decompensation text, General cirrhosis text |
Primary outcome
Delta knowledge scores between text and video education groups
Time frame: Baseline and immediately post-intervention (Day 1)
The delta score (post test minus pre test) was compared between text education and video education groups.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2025.
- Individual participant dataSharing planned: No
Related trials for Cirrhosis
Recruiting
CirrhosisRx CDS System
Cirrhosis, Decision Support Systems, Clinical
Enrolling by invitationPhase 4
Low Dose Versus Standard Dose Albumin
Decompensated Cirrhosis and Ascites
RecruitingObservational study
Treatment Outcomes and Predictors After Endovascular Intervention for Portal Hypertension-Related Gastrointestinal Bleeding in Cirrhosis
Cirrhosis, Portal Hypertension Related to Cirrhosis
RecruitingPhase 3
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
RecruitingPhase 3
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Video Education and Text education in people with Cirrhosis, run by University of Michigan at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Delta knowledge scores between text and video education groups (time frame: Baseline and immediately post-intervention (Day 1)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2025.